AI’s Race to Reinvent Medicine

About this session

AI is beginning to transform how new medicines are discovered, designed, and validated, from biological modeling and molecule design to autonomous experimentation and clinical development. This opening keynote brings together leaders from the companies defining the next era of life sciences R&D to discuss what is real today, what remains hype, and how AI could accelerate the path from scientific insight to patient impact.